Lansen Pharmaceutical Holdings Overview

  • Founded
  • 2001

Founded
  • Status
  • Public

  • Employees
  • 621

Employees
  • Stock Symbol
  • 00503

Stock Symbol
  • Investments
  • 2

  • Share Price
  • $0.15

  • (As of Monday Closing)

Lansen Pharmaceutical Holdings General Information

Description

Lansen Pharmaceutical Holdings Ltd is an investment holding company engaged in research and development, production, and sales of traditional Chinese medicines. Its operating segments are Pharmaceuticals, Cosmetics products, and Healthcare products. It generates a majority of revenue from the Pharmaceuticals segment, which includes the development, production, and sale of specialty pharmaceuticals mainly used in the field of rheumatology and dermatology, and other pharmaceuticals. The company's products include Xinshi indeed, Pavlin, Keshu syrup, Bazhen granules, Xinnaojian Capsule, Yahao-Dingbo Cream, and others. The group operates in the PRC and internationally, of which prime revenue is derived from the operations in PRC.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Holding Companies
Other Industries
Pharmaceuticals
Stock Exchange
HKG
Primary Office
  • 12/F., Li Po Chun Chambers
  • Suites 1203-4, 189 Des Voeux Road
  • Central
  • Hong Kong
+852 2828 0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Lansen Pharmaceutical Holdings Stock Performance

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.15 $0.15 $0.11 - $0.25 $64.8M 420M 74.5K $0.02

Lansen Pharmaceutical Holdings Financials Summary

In Thousands,
USD
TTM 30-Jun-2022 FY 2021 31-Dec-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019
EV 77,344 (20,150) 15,584 120,529
Revenue 62,686 54,180 54,386 54,257
EBITDA 8,987 5,255 95,871 26,439
Net Income 6,170 903 88,205 18,349
Total Assets 168,255 172,312 252,778 183,959
Total Debt 20,161 25,227 32,600 61,414
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Lansen Pharmaceutical Holdings Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Lansen Pharmaceutical Holdings Investments (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000000 31-Dec-2018 000000000 00.000 Biotechnology
Zhejiang Starry Pharmaceutical Company 01-Jan-2010 Corporate 000.00 Pharmaceuticals
To view Lansen Pharmaceutical Holdings’s complete investments history, request access »